Merck ready to quickly deploy Covid antiviral pill if it gets regulatory approval, CEO says

"We're on pace to have 10 million courses ready before the end of this year, and more than double that next year," Merck CEO Robert Davis told CNBC on Thursday.

from Health and Science https://ift.tt/3vViW7v
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH